InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Glicklich Alan, Directeur Médical. Director active across 1 company, notably Chinook Therapeutics, INC.. Aggregated, 5 reports have been recorded. Activity tracked since 16 June 2021. The latest transaction was filed on 16 June 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations5 total
5,668 sharesCommon StockSEC:0001209191-22-009563:0
7,103 sharesCommon StockSEC:0001209191-21-060111
7,103 sharesCommon StockSEC:0001209191-21-060111:0
20,000 shares@ US$0.4250.0% of flowCommon StockSEC:0001209191-21-041646
20,000 shares@ US$0.4250.0% of flowCommon StockSEC:0001209191-21-041646:0
5 of 5 declarations
About Glicklich Alan
Alan Glicklich is the Chief Medical Officer at Chinook Therapeutics, Inc. He oversees the company's medical and clinical activities, ensuring alignment with regulatory and ethical standards. Glicklich plays a key role in developing medical strategies and managing associated risks.
